Valuation: Becton, Dickinson and Company

Capitalization 5.94TCr 5.11TCr 4.77TCr 4.43TCr 8.25TCr 5,36300Cr 8.85TCr 55TCr 22TCr 2,56400Cr 22TCr 22TCr 9,40600Cr P/E ratio 2026 *
31.1x
P/E ratio 2027 * 26.5x
Enterprise value 7.51TCr 6.47TCr 6.03TCr 5.61TCr 10TCr 6,78300Cr 11TCr 69TCr 27TCr 3,24300Cr 28TCr 28TCr 11,89600Cr EV / Sales 2026 *
3.33x
EV / Sales 2027 * 3.12x
Free-Float
77.04%
Yield 2026 *
1.97%
Yield 2027 * 2.02%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.45%
1 week+1.54%
Current month+7.36%
1 month+4.13%
3 months+11.55%
6 months+16.85%
Current year+7.36%
More quotes
1 week 198.44
Extreme 198.44
209.27
1 month 192.48
Extreme 192.48
209.27
Current year 192.48
Extreme 192.48
209.27
1 year 162.29
Extreme 162.29
251.98
3 years 162.29
Extreme 162.29
287.32
5 years 162.29
Extreme 162.29
287.32
10 years 129.5
Extreme 129.5
287.32
More quotes
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Chief Tech/Sci/R&D Officer 56 04/12/2023
Compliance Officer - 01/02/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 20/11/2006
Director/Board Member 71 26/07/2010
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.45%+1.54%-10.42%-18.57% 5.94TCr
-0.68%-2.10%+11.19%+8.83% 21TCr
+0.26%+0.31%+15.93%+22.84% 13TCr
+1.55%+5.84%+49.51%+116.31% 6.89TCr
-0.74%+1.76%+25.15%+93.97% 5.47TCr
-1.61%+3.54% - - 3.55TCr
-0.66%+1.18%-13.88%-36.17% 2.7TCr
+1.52%+2.91%+29.81%+32.78% 2.63TCr
+1.34%-3.72%+5.77%-33.34% 2.4TCr
-2.03%-3.11%-25.48%+24.10% 2.09TCr
Average +0.10%+0.99%+9.73%+23.42% 6.58TCr
Weighted average by Cap. +0.38%+0.47%+13.83%+26.39%
See all sector performances

Financials

2026 *2027 *
Net sales 2.25TCr 1.94TCr 1.81TCr 1.68TCr 3.13TCr 2,03500Cr 3.36TCr 21TCr 8.17TCr 97TCr 8.44TCr 8.27TCr 3,56900Cr 2.33TCr 2.01TCr 1.87TCr 1.74TCr 3.24TCr 2,10600Cr 3.47TCr 21TCr 8.46TCr 1,00700Cr 8.74TCr 8.56TCr 3,69300Cr
Net income 202.12Cr 174.11Cr 162.26Cr 150.95Cr 280.82Cr 18TCr 301.24Cr 1.86TCr 733.58Cr 8.73TCr 757.92Cr 742.41Cr 32TCr 237.97Cr 204.99Cr 191.03Cr 177.72Cr 330.63Cr 22TCr 354.67Cr 2.19TCr 863.69Cr 10TCr 892.34Cr 874.09Cr 38TCr
Net Debt 1.57TCr 1.35TCr 1.26TCr 1.17TCr 2.18TCr 1,41900Cr 2.34TCr 14TCr 5.7TCr 68TCr 5.89TCr 5.77TCr 2,48900Cr 1.34TCr 1.15TCr 1.07TCr 997.53Cr 1.86TCr 1,20700Cr 1.99TCr 12TCr 4.85TCr 58TCr 5.01TCr 4.91TCr 2,11700Cr
More financial data * Estimated data
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
More about the company
Date Price Change Volume
15/26/15 208.35 $ +0.45% 21,70,974
14/26/14 207.42 $ +2.93% 14,42,810
13/26/13 201.52 $ -0.60% 11,58,393
12/26/12 202.74 $ -0.00% 13,81,370
09/26/09 202.75 $ -1.18% 13,21,253

Delayed Quote Nyse, January 16, 2026 at 02:30 am IST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
208.35USD
Average target price
206.67USD
Spread / Average Target
-0.81%
Consensus

Quarterly revenue - Rate of surprise